Evidence 1
Activity
Activity
0% hemolysis
Toxicity
250 µg/mL
Hemolytic
Cytotoxic
0% hemolysis | 250 | µg/mL | target cell: Human erythrocytes
Target
Human erythrocytes
Source & Reference
NA
DBAASP
Antimicrobial Activity of Novel Synthetic Peptides Derived from Indolicidin and Ranalexin against Streptococcus pneumoniae | PLoS One | 2015